Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Topical vitamin D is effective in treating vitiligo with few side effects.

Skin issues are common and important for diagnosing PCOS.

Covid-19 can cause hair loss due to immune and psychological factors.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Skin infections and eczema were most common in all ages, acne in teens and young adults, and nutritional skin problems and infestations in children.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Thyroid function may influence hair loss after COVID-19.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

Higher sebum levels are linked to more severe male baldness.

Most people getting cosmetic dermatology are young, educated, working women with a good income, mainly concerned about wrinkles and often choosing chemical peeling.

Focus on common skin diseases like eczema and infections to improve diagnosis and management.

The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.

Iron deficiency is linked to hair loss in CTE patients.

People with alopecia areata often have lower vitamin D levels than healthy people.